Citation

Ohtake Y, Sato T, Kobayashi T, Nishimoto M, Taka N, Takano K, Yamamoto K, Ohmori M, Yamaguchi M, Takami K, Yeu SY, Ahn KH, Matsuoka H, Morikawa K, Suzuki M, Hagita H, Ozawa K, Yamaguchi K, Kato M, Ikeda S.: Discovery of tofogliflozin, a novel C-arylglucoside with an O-spiroketal ring system, as a highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes. J Med Chem, Volume 55 (17), 2012

Authors

Ahn KH, Hagita H, Ikeda S., Kato M, Kobayashi T, Matsuoka H, Morikawa K, Nishimoto M, Ohmori M, Ohtake Y, Ozawa K, Sato T, Suzuki M, Taka N, Takami K, Takano K, Yamaguchi K, Yamaguchi M, Yamamoto K, Yeu SY

Journal

J Med Chem

Year

2012

DOI

10.1021/jm300884k

PubMed

22889351

Machine-readable

REST APIRDF